May 3, 2009
Are people who are on Isentress seeing raised lipids?
| Response from Dr. McGowan
Thanks for your post.
Although the data are not as deep as for some of our older treatments, the initial studies seem to show that Isentress (raltegravir, an HIV integrase inhibitor) is fairly lipid neutral. This has been seen in studies of people starting treatment for the first time (naives, Startmrk trial) and in switching from Protease inhibitors (Switchmrk trial). One caveat about the switch study was that after changing from a boosted PI to raltegravir, some people saw an increase in their viral load, so all such switches need to be done very carefully to be sure that the new combo has at least 3 active drugs in it.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.